Caryophyllene in Cannabis: β-Caryophyllene Actions and Properties

Caryophyllene, also known as β-caryophyllene (BCP), is a natural bicyclic sesquiterpene that plays an important role in the plant world. It is one of many components found in cannabis, but it is also present in many other plants around the world. Its unique properties and ability to interact with the endocannabinoid system, especially the CB2 receptor, have attracted the attention of researchers and scientists from various fields.

Studies confirm that caryophyllene has antioxidant, anti-inflammatory, immunomodulatory, and anti-cancer properties. Moreover, it does not produce psychoactive side effects associated with activation of the CB1 receptor, making it an attractive candidate for many therapeutic applications.

Where Can We Find Caryophyllene in Nature?

Although caryophyllene is one of the main components of cannabis, it is not exclusive to this plant. In fact, it is present in many plants around the world. It is found in many popular spices such as black pepper, basil, rosemary, and oregano. Due to its presence in many edible plants and culinary spices, caryophyllene is often consumed in the diets of many cultures.

Its rich occurrence in diverse plants makes it available to many people and constitutes an important part of traditional medicine in many cultures. Understanding its properties and potential health benefits may lead to further research into its applications in modern medicine.

In light of recent studies on the properties of caryophyllene, it has become a subject of interest among both scientists and consumers looking for natural health solutions. Its unique properties and presence in many readily available plants make it a valuable compound with many potential health benefits.

How Is Caryophyllene Produced in Cannabis?

The biosynthesis of caryophyllene in cannabis occurs through special enzymes called sesquiterpene synthases. This process starts from one of the basic building blocks of all terpenes, isoprene. In cannabis, the precursor for caryophyllene is a compound called farnesyl pyrophosphate (FPP). FPP is then converted into β-caryophyllene through the action of a specific enzyme.

Once formed, caryophyllene primarily accumulates in the resin glands of the cannabis plant, where it serves various functions, including defense against herbivores and attracting pollinating insects.

Factors Influencing Its Production

The production of caryophyllene in cannabis can vary depending on multiple factors:

1. Plant Genetics: Different strains of cannabis have varied terpene profiles, meaning some strains will produce more caryophyllene than others.
2. Growing Conditions: Light, temperature, humidity, and soil quality are crucial for the production of terpenes, including caryophyllene. For example, higher temperature and proper light exposure can increase terpene production in cannabis.
3. Plant Age: Younger plants typically produce fewer terpenes, while older plants that are closer to the flowering stage may increase caryophyllene production.
4. Stress: Cannabis plants, like other plants, increase terpene production in response to stress. For instance, mechanical damage, pest attacks, or extreme climatic conditions can prompt the plant to increase caryophyllene production for defense.
5. Cultivation Methods: The application of appropriate fertilization, irrigation, and pruning methods can influence the terpene profile of cannabis, including caryophyllene production.

Understanding these factors and their impact on caryophyllene production can be key for growers and researchers interested in optimizing the content of this compound in cannabis plants.

Different Types of Cannabis and Caryophyllene Content

Indica vs. Sativa

Cannabis is divided into two subspecies: Indica and Sativa. These two varieties differ not only in the plant morphology and effects upon consumption but also in their chemical profiles, including terpene content.

• Indica: Indica strains are generally shorter with dense and bushy stems. They tend to produce a relaxing, calming effect, which often correlates with a higher concentration of certain terpenes.
• Sativa: Sativa strains are taller with looser, sprawling stems. They tend to produce a more energetic, stimulating effect. Although Sativas can also contain caryophyllene, it often occurs at lower concentrations compared to Indicas.

It’s worth noting that the difference between Indica and Sativa is not absolute. In fact, there are many hybrid strains that combine features of both types and can contain varying concentrations of caryophyllene.

Most Popular Caryophyllene-Rich Strains

Some cannabis strains are known for their high caryophyllene content. Here are a few:

1. OG Kush: One of the most recognizable strains, OG Kush has an earthy, woody aroma with strong notes of caryophyllene.
2. Girl Scout Cookies (GSC): This strain, known for its rich terpene profile, contains distinct notes of caryophyllene that combine with other terpenes, creating a characteristic sweet-spicy aroma.
3. Bubba Kush: Bubba Kush is another Indica strain with high concentration, translating to its heavy, earthy scent.
4. Sour Diesel: Although it’s a Sativa strain, Sour Diesel is also known for the presence of caryophyllene, adding to its characteristic, sharp scent.
5. Cherry Pie: This strain is known for its sweet and fruity aroma with clear notes of caryophyllene, making it one of the more desirable strains for lovers of this terpene.

The exact caryophyllene content in individual strains can vary depending on growing conditions, plant genetics, and methods of processing and storage.

Caryophyllene’s Interaction with the Endocannabinoid System

Interaction with CB2 Receptors

The endocannabinoid system consists of receptors, mainly CB1 and CB2, and endogenous ligands for these receptors, known as endocannabinoids. Due to its unique chemical structure, caryophyllene can interact with this system, particularly with CB2 receptors.

CB2 receptors are primarily located in immune system cells and play a key role in modulating inflammatory processes and immune responses. Caryophyllene, as a selective agonist for these receptors, can activate them, eliciting pharmacological effects.

Unlike many other compounds from cannabis, caryophyllene does not bind to CB1 receptors, which means it does not produce psychoactive effects associated with a “high.”

Health Benefits

Due to caryophyllene’s ability to interact with CB2 receptors, it has a range of potential health benefits:

1. Anti-inflammatory Action: Activation of CB2 receptors may help inhibit inflammatory processes in the body, making caryophyllene potentially useful for treating inflammatory conditions such as arthritis.
2. Neuroprotection: Research suggests that caryophyllene may play a role in protecting nerve cells from damage, making it an interesting candidate for studies on neurodegenerative diseases.
3. Analgesic Effects: By interacting with the endocannabinoid system, caryophyllene may serve as a natural painkiller, which could be particularly beneficial in treating chronic pain.
4. Anticancer Effects: Some studies suggest that caryophyllene may inhibit the growth and proliferation of cancer cells, making it an interesting compound for further research in the context of oncology.
5. Impact on the Immune System: As an agonist of CB2 receptors, caryophyllene can modulate immune responses, which has potential applications in treating autoimmune diseases.

The ultimate health benefits associated with caryophyllene are still under scientific investigation, but initial findings are promising and indicate a wide range of potential therapeutic uses for this terpene.

How Does Caryophyllene Work in Cannabis?

Caryophyllene is one of many terpenes found in cannabis. Terpenes are organic chemical compounds responsible for the aroma and flavor of many plants, including cannabis. However, caryophyllene does more than just contribute to the plant’s characteristic scent and taste; it also has unique properties that affect how cannabis functions in the body.

1. Interaction with the Endocannabinoid System: Unlike most terpenes, caryophyllene can interact with the endocannabinoid system, specifically with CB2 receptors. These receptors are mainly present in the cells of the immune system and play a critical role in regulating inflammatory conditions in the body. As a selective agonist of CB2 receptors, caryophyllene can counteract inflammation and pain without inducing psychoactive effects, which are usually associated with THC and its interaction with CB1 receptors.
2. Analgesic and Anti-inflammatory Properties: As previously mentioned, caryophyllene has the ability to alleviate inflammation and pain, making it an attractive component in medical cannabis, especially in cases of chronic diseases or neuropathy.
3. Synergy with Other Cannabinoids: Terpenes, including caryophyllene, can work synergistically with other cannabinoids present in cannabis, such as THC or CBD. This means that the presence of caryophyllene can enhance or modify the effects of other cannabis compounds. This phenomenon is often referred to as the “entourage effect” and is the subject of research in the context of medical cannabis usage.
4. Lack of Psychoactive Effects: Although caryophyllene interacts with the endocannabinoid system, it does not produce psychoactive effects. This makes it appealing for those seeking the health benefits of cannabis without experiencing a “high.”

In summary, caryophyllene plays a pivotal role in the functioning of cannabis, influencing its anti-inflammatory, analgesic, and other potential therapeutic benefits. Its unique properties and ability to interact with the endocannabinoid system make it a valuable component for medical cannabis.

Medical Applications of Caryophyllene

Analgesic Properties

Studies indicate that caryophyllene, an active component in the essential oil from Ageratum conyzoides, has analgesic effects. Experimental studies in mice have shown that it helped in alleviating neuropathic pain. The study mentioned that the analgesic action is associated with the activation of opioid receptors and ATP-sensitive potassium channels. Additionally, an increase in spinal cord GABA concentrations was observed after administering caryophyllene.

Combating Inflammatory Conditions

Caryophyllene shows strong anti-inflammatory properties. Scientific studies have demonstrated that it can reduce pro-inflammatory mediators such as TNF-α, IL-1β, and IL-6. Its mechanism of action primarily relies on binding with cannabinoid CB2 receptors and interacting with receptors in the PPARs family. Due to this, it holds the potential to treat diseases associated with inflammation and oxidative stress, including metabolic and neurological disorders.

Potential Benefits for the Nervous System

Mitochondrial dysfunction leads to a range of defective cellular processes, including reduced ATP production or increased ROS production. These changes are particularly detrimental for neurons, which have a heightened demand for ATP. Caryophyllene, as a selective CB2 receptor agonist, shows antioxidant, analgesic, and anti-cancer properties. Studies suggest that it may stabilize mitochondria, which is key to protecting neurons. Moreover, its antioxidant activity could counteract the damage caused by mitochondrial dysfunction, making it a potential tool in treating neurodegenerative disorders.

Caryophyllene in Cannabis Summary

Caryophyllene is a chemical compound belonging to the terpenes, found in many plants, including cannabis. It is valued for its numerous health benefits, such as anti-inflammatory action, pain relief, and protection of the nervous system. It has also found application in the cosmetics industry as an ingredient in anti-aging and skincare products. Due to its interaction with CB2 receptors, it is a unique terpene that exhibits properties similar to some cannabinoids.

In summary, caryophyllene has a wide range of potential medical applications, including alleviating neuropathic pain, reducing inflammatory conditions, and protecting the nervous system from oxidative damage.

—

(Featured image by Esteban López via Unsplash)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.